Inflammatory Markers in Patients With Active Migraine Headaches
Does Migraine As A Partly Inflammatory Disease Increase The Inflammatory Markers Of The Patient When Actively Having a Migraine?
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 8, 2007
CompletedFirst Posted
Study publicly available on registry
May 10, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedAugust 8, 2011
February 1, 2009
May 8, 2007
August 5, 2011
Conditions
Keywords
Eligibility Criteria
Migraine
You may qualify if:
- Subjects must sign a written informed consent.
- Enrollment population would include males and females 21 years of age to 65 years of age.
- Non-migraine subjects will be allowed in the control group
- Have episodic migraine headaches
- Patients to satisfy the diagnosis of migraine headaches with aura, without aura or mixed.
- Must be able to differentiate migraine headaches from other headaches
You may not qualify if:
- Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
- Basilar or hemiplegic migraine headaches.
- Pregnant woman or a nursing mother
- History (within 1 year) or current evidence of drug or alcohol abuse.
- More than 15 migraine headaches per month
- Chronic daily headaches
- Chronic use of NSAIDs
- Current participation in a research study or within the last 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Westside Family Medical Center, P.C.lead
- GlaxoSmithKlinecollaborator
Study Sites (1)
Westside Family Medical Center, P.C.
Kalamazoo, Michigan, 49009, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary E Ruoff, MD
Westside Family Medical Center, P.C.
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 8, 2007
First Posted
May 10, 2007
Study Start
May 1, 2007
Study Completion
February 1, 2009
Last Updated
August 8, 2011
Record last verified: 2009-02